California AB-2300 Position Statement

Baxter’s mission is to save and sustain lives, with patient safety and care continuity our top priorities. We are committed to delivering a range of essential products that both support evolving customer preferences and meet new regulatory and governmental requirements, including expanding our existing portfolio of more than 150 non-DEHP IV container and tubing products in compliance with California bill AB-2300, Medical Devices: Di-(2-ethylhexyl) phthalate (DEHP).    

Baxter is proud to serve as the largest supplier of IV fluids in the United States. We applaud Governor Newsom and the California legislature for diligence in arriving at appropriate implementation timelines in the interest of protecting supply continuity and therefore patient care. We are focused on helping to ensure a reliable supply of these essential products in the market – a responsibility that involves both our comprehensive transition as a manufacturer as well as large-scale conversions for healthcare providers.   

As we continue our thoughtful and significant conversion efforts, Baxter stands behind the safety of our current products, which are FDA approved and proven to help save and sustain millions of lives.